Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-21-030557)

Filing Details

Accession Number:: 0001213900-21-030557
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-02 16:37:52
Reporting Period:: 2021-06-01

Accepted Time:: 2021-06-02 16:37:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1726711	Aditx Therapeutics Inc.	ADTX	Pharmaceutical Preparations (2834)	823204328

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1816754	Shahrokh Shabahang	C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043	Chief Innovation Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-01	490	$2.93	1,016,098	No	4	P	Indirect	By son

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By son

Footnotes

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.